Target intelligence / Profile preview

ATP6V0E2 antisense RNA 1 (ATP6V0E2-AS1)

Target
ATP6V0E2-AS1
Molecular classification
Long non-coding RNA (lncRNA), Antisense RNA, Other
01

Overview

ATP6V0E2 antisense RNA 1 (ATP6V0E2-AS1) is a long non-coding RNA (lncRNA) gene transcribed from the antisense strand of the ATP6V0E2 locus. This RNA belongs to the lncRNA and natural antisense transcript molecular classes, meaning it does not code for a protein but may regulate expression of its sense counterpart gene (ATP6V0E2) or other local/regional genes. General roles for antisense RNAs include modulation of splicing, transcription, RNA stability, and translation, often in cis, but the specific molecular and biological function of ATP6V0E2-AS1 remains incompletely characterized. According to public gene databases, variants or altered expression of ATP6V0E2-AS1 may be associated with rare metabolic diseases, such as infantile hypophosphatasia. However, there is no direct evidence that ATP6V0E2-AS1 is a therapeutic target, nor are there any known drugs, clinical biomarkers, or notable safety concerns currently linked to this RNA[7][2][8].

Other names
ATP6V0E2-AS1ATP6V0E2 antisense RNA 1 (non-protein coding)
02

Biological functions

Regulation of gene expressionLikely regulation of ATP6V0E2 gene (by antisense mechanism)Other
03

Disease associations

Hypophosphatasia, infantileHypophosphatasia(generic lncRNA roles may impact various diseases, but no specific high-confidence associations found beyond above)

Beyond the preview

Go deeper on ATP6V0E2 antisense RNA 1 (ATP6V0E2-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ATP6V0E2 antisense RNA 1 (ATP6V0E2-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call